focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHRM.L Regulatory News (PHRM)

  • There is currently no data for PHRM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Updated Appendix to Schedule 1

31 Aug 2012 15:49

RNS Number : 2663L
Phorm Inc
31 August 2012
 



 

31 August 2012

 

Phorm, Inc. ("Phorm" or the "Company")

 

Updated Appendix to Schedule 1 and Correction to Announcements

 

Further to the announcement of 13 August 2012 regarding the Company's re-domicile to Singapore, the Company announces that it has uploaded an updated Appendix to the AIM Schedule 1 to its website at www.phorm.com.

 

The updated Appendix includes the following amendments to the Additional Information on the Directors of the Company:

 

·; The inclusion of the directorships of the newly incorporated Phorm Corporation Limited and Phorm Redom Corporation;

·; The amendment to directorships of Mark Schneider, Lord Lamont and Andrew Croxson; and

·; The inclusion of additional information in relation to a past directorship of Kent Ertugrul, Hamburger Halt Limited.

 

Further to the announcement of 19 June 2012, and under Schedule 2(g) of the AIM Rules in relation to the past and present directorships of Andrew Croxson, the announcement omitted his present directorships of Phorm Advertising and Content SRL, PT Reklam Çözümleri Ticaret Ve Servis A.Ş.and Phorm Solutions Korea, Inc. and his past directorship of Ingenious Consulting Associates Limited.

 

In addition, further to the announcement of 1 December 2008, and under Schedule 2(g) of the AIM Rules in relation to the past and present directorships of Lord Lamont, the announcement omitted his present directorships of The British-Iranian Chamber of Commerce and JSST Securities Limited and his past directorships of The British Romanian Chamber of Commerce and Anglo Arabian Projects Limited, as well as Pacific Life Re Limited, Pacific Life Re Services Limited, Tartan Financial (UK), Tartan Holdings (UK) Limited and JFIT Securities Limited (each of which are subsidiaries of entities disclosed at that time).

 

In addition, further to the announcement of 16 August 2010, and under Schedule 2(g) of the AIM Rules in relation to the past and present directorships of Mark Schneider, the announcement omitted his present directorships of ShortsTV France Limited, Shorts International Limited and his past directorship of Music Choice Europe Limited.

 

 

For Enquiries

Phorm, Inc.

Mark Williams (analysts & investors) +44 20 7297 2326

Alex Laity (media) +44 20 7297 2710

 

Liberum Capital +44 20 3100 2222

(Nominated Advisor and Joint Broker)

Chris Bowman

Richard Bootle

 

Mirabaud Securities LLP +44 20 7321 2508

(Joint Broker)

Jason Woollard

Peter Krens

 

Hudson Sandler +44 20 7796 4133

Charlie Jack

Charlie Barker

 

- ends -

 

 

About Phorm

Phorm is a global personalisation technology company that makes content and advertising more relevant to the consumer. Phorm's innovative platform preserves user privacy and delivers a more interesting online experience.

 

Phorm's partners include leading Internet Service Providers (ISPs), Publishers, Ad Networks and Advertisers.

 

A Delaware, US incorporated company, Phorm was admitted to the AIM market of the London Stock Exchange in 2004 and has over 140 employees and contractors.

For more information, please visit: www.phorm.com.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEALPFDLPAEFF
Date   Source Headline
19th Jun 20127:00 amRNSAGM Statement
1st Jun 20127:00 amRNS£20m equity fundraising into Phorm China
1st Jun 20127:00 amRNSIntention to Re-Domicile
22nd May 20127:00 amRNSPhorm Announces AGM Notice & Proposed Board Change
21st Mar 20127:00 amRNSAppointment of Nominated Adviser and Joint Broker
5th Mar 20127:00 amRNSTransfer of Shares
1st Mar 20127:00 amRNSTransfer of Shares
28th Dec 20117:00 amRNSDirector Dealing
12th Dec 201110:10 amRNSTransfer of Shares
7th Dec 201110:19 amRNSTransfer of Shares
2nd Dec 20112:02 pmRNSTR-1: Notification of Major Interest in Shares
2nd Dec 201112:16 pmRNSTransfer of Shares
11th Nov 20117:30 amRNSIssue of Equity
4th Nov 20117:30 amRNSIssue of Equity
21st Oct 20113:28 pmRNSIssue of Equity
20th Oct 20114:14 pmRNSTransfer of Shares
7th Oct 20112:00 pmRNSBlock Admission Return
30th Sep 20117:00 amRNSInterim Results for Six Months Ended 30 June 2011
28th Sep 20117:00 amRNSProduct Launch
30th Jun 20117:00 amRNSAnnual Financial Report
8th Apr 201112:00 pmRNSBlock Admission Return
30th Mar 20117:00 amRNSTR-1: Notification of Major Interest in Shares
22nd Mar 20117:00 amRNSPlacing and operating update
2nd Mar 201112:00 pmRNSTransfer of Shares
1st Feb 201110:14 amRNSResult of AGM
6th Jan 20117:15 amRNSOption Grant and Modification
6th Jan 20117:05 amRNSAdvisory Board Appointment - Juan Villalonga
24th Dec 20108:11 amRNSNotice of AGM
17th Dec 20109:11 amRNSIssue of convertible secured loan notes
8th Oct 20105:25 pmRNSBlock Admission Return
30th Sep 20107:00 amRNSInterim results
22nd Sep 20107:00 amRNSUpdate on Commercial Deployment in Brazil
17th Aug 20103:42 pmRNSCorrection re Share Transfer
16th Aug 20103:58 pmRNSShare Transfer
16th Aug 20108:50 amRNSDirectorate Change
30th Jul 20101:00 pmRNSTransfer of Shares
23rd Jul 201011:17 amRNSDirectorate Change
16th Jul 20104:25 pmRNSTransfer of Shares
9th Jul 20107:00 amRNSTransfer of Shares
7th Jul 20104:55 pmRNSDirector/PDMR Shareholding
7th Jul 20102:19 pmRNSPlacing of Shares
30th Jun 20102:17 pmRNSAnnual Report & Accounts Notification
30th Jun 20107:00 amRNSPreliminary Results
28th Jun 20107:00 amRNSNotification of results
8th Jun 20102:05 pmRNSChange in name of Nominated Adviser
30th Apr 20101:08 pmRNSGrant of options
9th Apr 20105:25 pmRNSBlock Admission Return
26th Mar 20107:00 amRNSCommercial Deployment in Brazil
28th Jan 20104:37 pmRNSNotification of Major Interest in Shares
11th Jan 20104:28 pmRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.